Back in October, Zuckerberg, seeing plunging user numbers and fading growth, desperately renamed Facebook, once the world’s foremost purveyor of misinformation and unethical aggregator of… Read More »Metaverse and mental health therapy – another psychedelics sector roundup
Environmental, Social and Governance (ESG) focused investment is a relatively new accepted method for socially conscious investors to allocate their investment capital in public/private companies… Read More »Do ethics matter when you invest? – another psychedelics sector roundup
Health Canada stepped up to the plate back in December with a Notice of Intent to amend the Food and Drug Regulations and the Narcotic… Read More »What does Health Canada’s amendment proposal mean for psychedelics? – another sector roundup
We’re living in interesting times and I mean that in the Chinese curse kind of way. We can’t seem to stop to catch our breath… Read More »MYND Life Sciences (MYND.C) provides unorthodox route to better mental health
Welcome to Equity.Guru’s Roundtable where our writers weigh in on the pros and cons of a spotlight company, break out where they see value, and… Read More »MYND Life Sciences (MYND.C) – Investor Roundtable Video
MYND Life Sciences Inc. is a medical biotech drug research and development company focused on neuro-pharmaceutical and novel psilocybin drug development, diagnostics and vaccines. The… Read More »Chart Attack: MYND Life Sciences (MYND.CN) Double Bottom Reversal Watch as Psychedelics Continue to Bleed
Psychedelics have showed tremendous potential in treating neurological conditions such as major depressive disorder, PTSD, ALS, and generalized anxiety. Investors jumped on the opportunity, sending… Read More »Can we trust the science of psychedelics? Another sector roundup.
The psychedelics space is loaded with over-valued unicorns and also-rans, making it difficult for investors to find real growth opportunities. Here are some companies in… Read More »Small cap psychedelics stocks – Today’s Idea
Looking at the charts of the Psychedelics sector, they can best be described as a mixed bag. Just like Cannabis, shroom stocks are taking a… Read More »Chart Attack: Psychedelic Stocks Crater, A Technical Roundup MYND.C, MCUR.C, PHRM.C, NEON.C
In this episode, we take a look at 3 Canadian psychedelic stocks with potential: MYND Life Science (MYND.C), Mind Cure Health Inc. (MCUR.C), NeonMind Biosciences… Read More »Canadian Psychedelic Stocks – To Invest or Not
